Arthritis Foundation and Takeda Launch Let’s Speak Gout to Encourage Better Disease Management for Patients with Gouty Arthritis
Takeda Pharmaceuticals North AmericaThe Arthritis Foundation and Takeda Pharmaceuticals U.S.A., Inc. (Takeda) launched Let’s Speak Gout, a program based on new joint research, that offers tools for health care professionals and patients to make more effective gouty arthritis (“gout”) management a priority.
RSS